Response by van Doorn et al to Letters Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
Publication date
2024-07-09
Authors
van Doorn, Sander
Rutten, Frans
Geersing, Geert-Jan
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Cardiology and Cardiovascular Medicine, Physiology (medical)
Citation
van Doorn, S, Rutten, F H & Geersing, G J 2024, 'Response by van Doorn et al to Letters Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation : Results of the FRAIL-AF Randomized Controlled Trial”', Circulation, vol. 150, no. 2, 124.070172, pp. e30-e32. https://doi.org/10.1161/CIRCULATIONAHA.124.070172